|
Zaragoza-Huesca D, Nieto-Olivares A, Garcia-Molina F, Ricote G, Montenegro S, Sanchez-Canovas M, Garrido-Rodriguez P, Penas-Martinez J, Vicente V, Martinez F, Lozano ML, Carmona-Bayonas A, Martinez-Martinez I. Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients. Cancers (Basel). 2022 Jun 24;14(13):3106. doi: 10.3390/cancers14133106. PubMed PMID: 35804878; PubMed Central PMCID: PMC9264764.
AÑO: 2022; IF: 6.575
|
35804878
|
Bravo-Perez C, Toderici M, Chambers JE, Martinez-Menarguez JA, Garrido-Rodriguez P, Perez-Sanchez H, de la Morena-Barrio B, Padilla J, Minano A, Cifuentes-Riquelme R, Vicente V, Lozano ML, Marciniak SJ, de la Morena-Barrio ME, Corral J. Full-length antithrombin frameshift variant with aberrant C-terminus causes endoplasmic reticulum retention with a dominant-negative effect. JCI Insight. 2022 Oct 10;7(19):e161430. doi: 10.1172/jci.insight.161430. PubMed PMID: 36214221; PubMed Central PMCID: PMC9675572.
AÑO: 2022; IF: 9.484
|
|
Paramo JA, Lozano ML, Gonzalez-Porras JR, Mateo J. Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT). Med Clin (Barc). 2022 Jan 21;158(2):82-89. doi: 10.1016/j.medcli.2021.05.020. Epub 2021 Jul 24. No abstract available. English, Spanish. PubMed PMID: 34311973.
AÑO: 2022; IF: 3.9
|
|
Lozano ML, Rodeghiero F. Thrombopoietin receptor agonist in chemotherapy-induced thrombocytopenia. Lancet Haematol. 2022 Mar;9(3):e168-e169. doi: 10.1016/S2352-3026(22)00030-8. No abstract available. PubMed PMID: 35240068.
AÑO: 2022; IF: 24.7
|
|
de la Morena-Barrio ME, Suchon P, Jacobsen EM, Iversen N, Minano A, de la Morena-Barrio B, Bravo-Perez C, Padilla J, Cifuentes R, Asenjo S, Deleuze JF, Tregouet DA, Lozano ML, Vicente V, Sandset PM, Morange PE, Corral J. Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays. Blood. 2022 Jul 14;140(2):140-151. doi: 10.1182/blood.2021014708. PubMed PMID: 35486842; PubMed Central PMCID: PMC9283966.
AÑO: 2022; IF: 20.3
|